LAG3 and neoplasm: Emerging research is also focusing on newer, less studied immune checkpoint receptors, such as lymphocyte gene 3 (LAG3) and T cell immunoglobulin and mucin protein (TIM3), which can be co-expressed on exhausted PD-1 T cells in the tumor microenvironment, promoting anti-tumor immune evasion [1].